Clicky

Supernus Pharmaceuticals Inc(S49) News

Date Title
May 21 3 Cash-Heavy Stocks in the Doghouse
Apr 24 3 Healthcare Stocks with Mounting Challenges
Apr 23 Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025
Feb 11 Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
Feb 4 Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
Jan 30 7MM PD market to grow by $4.5bn between 2023 and 2033
Jan 7 Supernus Pharmaceuticals (NASDAQ:SUPN) shareholders have earned a 9.4% CAGR over the last five years